> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Controlled Correspondence for Generics
- URL: https://www.fdaweb.com/draft-guide-on-controlled-correspondence-for-generics/
- Published: 2017-11-03T12:00:00.000Z
- Updated: 2026-09-14T22:59:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140047

*Federal Register* notice: FDA has made available a draft guidance on “Controlled Correspondence Related to Generic Drug Development.” The document describes the process by which generic drug manufacturers and related industry can submit requests to clarify ambiguities in FDA’s controlled-correspondence response and the process for responding to those requests. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-11-03/pdf/2017-23947.pdf?ref=fdaweb.com).